How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Omega 9 Nutritional Supplements Market
- By Product Form: Softgel Capsules, Liquid Oils, Powdered Supplements, Chewable Tablets, Functional Beverages
- By Source: Olive Oil, Almond Oil, Avocado Oil, Macadamia Nut Oil, Animal-Based Sources
- By Application: Cardiovascular Health, Cognitive Function, Anti-Inflammatory Support, Skin Health, Weight Management
- By Distribution Channel: Pharmacies and Drug Stores, Online Retail, Health and Wellness Stores, Supermarkets and Hypermarkets, Direct Selling
- By End User: Adults, Athletes and Fitness Enthusiasts, Elderly Population, Pregnant and Lactating Women
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Softgel Capsules leads By Product Form at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 303 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.184 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.192 →
Full report · locked preview
Everything inside the Omega 9 Nutritional Supplements Market report
A complete, evidence-based study - 12 chapters and 127 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Amway
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →GNC Holdings Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Herbalife Nutrition Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →NOW Foods
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Nature's Bounty Co.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →NutraScience Labs
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Solgar Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Nordic Naturals
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Carlson Labs
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Barlean's Organic Oils
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Jarrow Formulas
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Swanson Health Products
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Life Extension
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Garden of Life
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →MegaFood
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Softgel Capsules39.0
- Liquid Oils18.7
- Powdered Supplements14.9
- Chewable Tablets17.8
- Functional Beverages9.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Amway20.4
- GNC Holdings Inc.15.3
- Herbalife Nutrition Ltd.11.0
- NOW Foods5.3
- Nature's Bounty Co.11.8
- NutraScience Labs8.3
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.4
- Europe23.2
- Asia Pacific21.8
- Latin America13.8
- Middle East and Africa8.8
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Amway | 84 | 85 | 90 | 90 | 84 | 85 | 86 |
| GNC Holdings Inc. | 82 | 87 | 72 | 87 | 92 | 80 | 83 |
| Herbalife Nutrition Ltd. | 80 | 65 | 67 | 77 | 66 | 75 | 72 |
| NOW Foods | 73 | 64 | 70 | 75 | 82 | 64 | 71 |
| Nature's Bounty Co. | 67 | 52 | 61 | 67 | 71 | 73 | 65 |
| NutraScience Labs | 69 | 50 | 65 | 65 | 46 | 47 | 57 |
| Solgar Inc. | 56 | 64 | 51 | 42 | 44 | 50 | 51 |
| Nordic Naturals | 56 | 44 | 44 | 37 | 35 | 44 | 43 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Amway
- GNC Holdings Inc.
- Herbalife Nutrition Ltd.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Amway | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| GNC Holdings Inc. | ✓ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Herbalife Nutrition Ltd. | ✓ | − | ◐ | ✓ | − | − |
| NOW Foods | ◐ | ◐ | ◐ | − | ◐ | ◐ |
| Nature's Bounty Co. | ◐ | ◐ | − | − | ✓ | ✓ |
| NutraScience Labs | ◐ | − | ◐ | ◐ | ◐ | − |
| Solgar Inc. | − | − | ◐ | − | − | ◐ |
| Nordic Naturals | ◐ | − | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Challenger2
Strong scale, closing on the leaders.
Contender2
Focused players with pockets of strength.
Niche2
Specialists in a single segment or region.
Go-to-market strategy
Land Product Form in North America, then scale across Omega 9 Nutritional Supplements Market — a $283M beachhead inside a $3.95B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Softgel Capsules
Best fit — highest urgency & budget in Product Form.
Liquid Oils
Strong fit — clear ROI and a fast path to value.
Powdered Supplements
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Form in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Source & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Product Form leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Omega 9 Nutritional Supplements Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Omega 9 Nutritional Supplements Market is a durable-growth opportunity — $1.42B by 2033, compounding at 7.4%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.4% CAGR
Demand compounds through 2033, outpacing GDP across Product Form.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Form moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Source optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Omega 9 Nutritional Supplements Market — a $5.84B market by 2033. Plan: grow share from 7.8% to 17.1%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.8% | 17.1% | At risk |
| Revenue | $420M | $999M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 32.2% | 41.5% | On track |
| Customer retention | 86.7% | 92.6% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Product Form
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Source capability
A defensible second engine — invest in Source to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Form share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Source
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $114M capacity & capability investment
- Greenlight bolt-on M&A in Source
- Authorise North America expansion plan
- Fund R&D program for Product Form leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossAhead
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentBehind
Sales deck · value proposition
Win the Omega 9 Nutritional Supplements Market conversation — a $8.80B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Form
Goal Grow share in Product Form
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Omega 9 Nutritional Supplements Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Omega 9 Nutritional Supplements Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Omega 6 Nutritional Supplements Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportOmega 3-6-9 Nutritional Supplements Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportOmega 3 Nutritional Supplements Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportAbdominal Wheels Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportConveyor Systems for Medical Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportConveyors for the Medical Market
Market size, share, segmentation and regional forecast.
$549M market · 2025 base year
View reportBody Fat Scales Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportBMI Calculator Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportPediatric Beds Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportExhalation Valves Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportConvex Ultrasound Probes Market
Market size, share, segmentation and regional forecast.
$805M market · 2025 base year
View reportConvex-Array Ultrasound Transducer Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy